Morepen Laboratories Ltd. News and Updates

Keep track of all breaking news on Morepen Laboratories Ltd. from all sources in a single place.

Morepen Laboratories Ltd.

12 May 2025

47.90

3.26%

Morepen Laboratories Q4 Results: Net Profit Dips 31% To Rs 20 Crore

NDTV Profit

The company's total income rose to Rs 470 crore, up from Rs 427 crore in the corresponding quarter of the previous year, according to a regulatory filing.

Morepen Laboratories Ltd. has lost -23.40% in the last 1 Month

Morepen Lab Q4 net profit falls 31% to 20.31 cr, income up 10% at 470 cr

Business Standard | 12 May 2025 1 more

Morepen Laboratories Ltd.

12 May 2025

47.90

3.26%

to see Rapid results content

Morepen Laboratories Ltd.

29 Apr 2025

47.90

3.26%

Morepen gets regulatory clearance for fatty liver drug development

Business Line

The shares of Morepen Laboratories Limited were trading at 62.36 up by 0.31 or 0.50 per cent on the NSE at 10 am

Morepen Laboratories Ltd. has lost -20.92% in the last 3 Months

Morepen Laboratories Ltd.

24 Apr 2025

47.90

3.26%

Morepen stock soars over 14% on growth plans

Business Line

Morepen Laboratories said its 325-crore formulation business was targeting 1,000 crore in five years, on the back of local and global sales

Number of FII/FPI investors decreased from 57 to 49 in Jun 2025 qtr

Morepen Laboratories Ltd.

19 Apr 2025

47.90

3.26%

Morepen Labs Targets Rs 5,000 Crore Revenue By FY30

NDTV Profit

Morepen Labs aims for a 15% to 16% Ebitda margin over the next five years, and could achieve a margin of 20% in the longer run, its CMD suggested.

Number of FII/FPI investors decreased from 57 to 49 in Jun 2025 qtr

Morepen Laboratories Ltd.

11 Apr 2025

47.90

3.26%

Morepen to hire 1,000 medical representatives to boost formulations biz

Business Standard

Morepen Laboratories on Friday said it will add more than 1,000 medical representatives over the next three years, with over 200 team members expected to join in FY26 alone. The company aims to strengthen its formulations business in the market through new hirings. "This expansion represents a pivotal moment in Morepen's journey as we sharpen our focus on the expanding domestic finished dosage market," Morepen Laboratories Chairman and MD Sushil Suri said in a statement. With significant increase in the sales force and enhanced reach to doctors, pharmacies, and patients, the drugmaker is setting the stage for getting a bigger pie in the Indian pharmaceutical market valued at Rs 2.38 lakh crore, yielding higher gross margins and better returns for stakeholders in the long run, he added. Currently, Morepen's formulation business stands around Rs 325 crore, and the company is targeting to touch Rs 1,000 crore in the next five years. This goal will be supported by an aggressive expans

Morepen Laboratories Ltd. is trading below all available SMAs

Morepen Laboratories Ltd.

01 Apr 2025

47.90

3.26%

Morepen Labs rises 4% after China approves anti-allergy API export

Business Standard

The company commands an over 80 per cent market share in the US generics market for Loratadine, according to its filing

Morepen Laboratories Ltd. has lost -20.92% in the last 3 Months

Morepen Laboratories secures approval for Loratadine API in China

Business Line | 01 Apr 2025

Morepen Laboratories Ltd.

18 Mar 2025, 11:05AM

47.90

3.26%

Morepen Labs shares skyrocket 12% on rolling out 'Empamore'; details here

Business Standard

The uptick in the Morepen Labs share came after the company announced that it has rolled out 'Empamore.'

Morepen Laboratories Ltd. has lost -23.40% in the last 1 Month

Morepen Laboratories Ltd.

10 Feb 2025

47.90

3.26%

Volume shocker: Morepen Labs falls 18% as nearly 8 mn shares change hands

Business Standard

Morepen Labs share price: Volumes on the Morepen Labs counter jumped suddenly around 1:05 PM with around 1.67 million shares changing hands in multiple tranches on the BSE